Pharming (PHAR) Goodwill & Intangibles (2019 - 2026)
Pharming (PHAR) posted Goodwill & Intangibles of $131.0 million for Q1 2026, down 3.36% on a QoQ basis from $135.5 million in Q4 2025, and down 5.67% year-over-year from $138.9 million in Q1 2025.
Pharming (PHAR) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Pharming's Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $131.0 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 5.67% year-over-year to $131.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.0 million (down 5.67% YoY) and the FY2025 annual result came in at $135.5 million, up 122.05% from the prior year.
- Goodwill & Intangibles was $131.0 million for Q1 2026 at Pharming, down from $135.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $138.9 million in Q1 2025 and bottomed at $70123.0 in Q3 2022.
- A 5-year average of $86.0 million and a median of $75.1 million in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles plunged 99.92% — and 2023, when it soared 99509.26%.
- Pharming's Goodwill & Intangibles stood at $75.1 million in 2022, then declined by 5.13% to $71.3 million in 2023, then declined by 14.35% to $61.0 million in 2024, then surged by 122.05% to $135.5 million in 2025, then declined by 3.36% to $131.0 million in 2026.
- Business Quant data shows PHAR's Goodwill & Intangibles at $131.0 million in Q1 2026, $135.5 million in Q4 2025, and $134.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.99 Mn |
| Dec 31, 2025 | 135.54 Mn |
| Sep 30, 2025 | 134.93 Mn |
| Jun 30, 2025 | 135.90 Mn |
| Mar 31, 2025 | 138.86 Mn |
| Dec 31, 2024 | 61.04 Mn |
| Sep 30, 2024 | 67.10 Mn |
| Jun 30, 2024 | 66.57 Mn |
| Mar 31, 2024 | 68.30 Mn |
| Dec 31, 2023 | 71.27 Mn |
| Sep 30, 2023 | 69.85 Mn |
| Jun 30, 2023 | 73.41 Mn |
| Mar 31, 2023 | 75.61 Mn |
| Dec 31, 2022 | 75.12 Mn |
| Sep 30, 2022 | 70,123.00 |
| Jun 30, 2022 | 75.77 Mn |
| Mar 31, 2022 | 81.32 Mn |
| Sep 30, 2021 | 89.01 Mn |
| Jun 30, 2021 | 91.39 Mn |
| Mar 31, 2021 | 89,943.00 |